<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/F75103EE-8294-429F-BC9F-70CBED7DA893"><gtr:id>F75103EE-8294-429F-BC9F-70CBED7DA893</gtr:id><gtr:name>St Jude Children's Hospital</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:department>Sch of Life Sciences</gtr:department><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F75103EE-8294-429F-BC9F-70CBED7DA893"><gtr:id>F75103EE-8294-429F-BC9F-70CBED7DA893</gtr:id><gtr:name>St Jude Children's Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/6801518B-C8E0-47A7-B97F-836705903CA0"><gtr:id>6801518B-C8E0-47A7-B97F-836705903CA0</gtr:id><gtr:firstName>Keith</gtr:firstName><gtr:surname>Caldecott</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=MR%2FJ006750%2F1"><gtr:id>18ADE4D6-6D63-4B41-A6FD-99C2554B6FFF</gtr:id><gtr:title>Chromosomal Single-Strand Break Repair: Mechanisms and Degenerative Disease</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/J006750/1</gtr:grantReference><gtr:abstractText>Breaks in the genetic material (DNA) can lead to a variety of hereditary and age-related diseases, including cancer and neurodegeneration. Whilst the causal link between DNA breaks and cancer is quite well understood, the causal link between DNA breaks and degeneration of the nervous system is not. The aim of the proposed programme is to address critical unanswered questions and new hypotheses concerning the mechanism/s by which breaks in a single strand of DNA (DNA single-strand breaks) are repaired, and the link between this process and degenerative disease. Understanding how DNA single-strand breaks can cause neurodegeneration is important not only for understanding hereditary diseases associated with neurological dysfunction (and hopefully in future for treating and managing such diseases), but most likely also for understanding degenerative diseases associated with normal ageing. This is because DNA single-strand breaks are the commonest lesions arising in cells and are a product of oxidative stress, which in turn is a major etiological factor in pathologies associated with ageing. Indeed, our recent experiments reveal that loss of the critical DNA single-strand break repair protein XRCC1 results in premature onset of molecular and pathological hallmarks of ageing and, moreover, that un-repaired DNA damage in the brain can trigger these hallmarks, systemically (i.e. in undamaged tissues). In addition, we have identified molecular links between the DNA damage response and the hereditary neurodegenerative disease ataxia oculomotor apraxia-2, which we propose identifies a new component of the cellular control of gene expression in the presence of DNA lesions and can explain the basis of this disease. We will now pursue our recent novel findings and hypotheses in this research Programme. In particular, we will address critical questions concerning the organisation and importance of DNA single-strand break repair in vivo, focussing on a novel unidentified role for XRCC1 and on the mechanism by which this protein is recruited at single-strand breaks, and on how DNA single-strand break repair impacts on hereditary and ageing-related degenerative disease. Ultimately, we envisage this work will identify new avenues for treatment &amp;amp; management of degenerative diseases that are associated, wholly or partly, with DNA breakage.</gtr:abstractText><gtr:technicalSummary>The aim of the proposed programme is to address critical unanswered questions and new hypotheses concerning mechanism/s of DNA single-strand break repair and the link between this process and human degenerative disease. For example, we will employ molecular and cellular approaches to pursue the new molecular links we have uncovered between the response to DNA strand breaks and the hereditary neurodegenerative disease, ataxia oculomotor apraxia-2. This work will involve the use of siRNA and gene targeting technology in human, DT40, and murine cells, in conjunction with biochemical assays that measure DNA strand break repair and related processes in vitro. The proposed programme is relevant not only to hereditary neurodegenerative disease, however, but also to degenerative pathologies associated with normal human ageing. This is because we have found that loss of the critical DNA single-strand break repair scaffold protein XRCC1 in brain results in premature onset of molecular/pathological hallmarks of ageing, systemically. We will thus also pursue these findings in the new Programme, using not only the cellular model systems described above but also physiological approaches. Finally, we will address key unanswered questions concerning the organisation and importance of DNA single-strand break repair in vivo, focussing on a critical but unidentified role for XRCC1, and on how XRCC1 function is modulated within the context of chromatin by the proteins APLF and PARP-1. To do this, we will again employ a combination of biochemical, cellular, and physiological approaches. Together, the experiments proposed in this research Programme will enable us to address both critical unanswered questions concerning cellular mechanisms of DNA single-strand break repair and also the pathophysiological consequences of not repairing such breaks.</gtr:technicalSummary><gtr:potentialImpactText>Beyond academia and related research fields, the work in this Programme has the potential to impact, in the long-term, on the health sector and 'quality of life'/'Lifelong Health and Wellbeing'. This is because the Programme will address the possible impact of DNA single-strand breaks on the maintenance of normal neurological function and on molecular hallmarks/pathologies associated with normal ageing. For example, the programme will investigate the link between un-repaired DNA strand breaks and progressive, debilitating, degeneration of the nervous system in the hereditary genetic disease, ataxia oculomotor apraxia-2. In addition, the programme will investigate the link between un-repaired single-strand breaks in the brain and consequent down-regulation of growth hormone signalling in the liver; a molecular hallmark of normal ageing that can influence pathologies such as osteoporosis. A thorough understanding of the relationship between un-repaired SSBs and pathologies associated with hereditary neurodegenerative disease and with age could thus help inform the health sector in respect to etiological factors that promote degenerative disease and 'unhealthy' ageing (e.g. environmental factors that induce excessive SSBs). This research could thus, in the long-term, inform on environmental and life-style issues relating to 'quality of life' and 'Lifelong Health and Wellbeing'.</gtr:potentialImpactText><gtr:fund><gtr:end>2017-04-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2088526</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>St Jude Children's Hospital</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>McKinnon and Mouse Models</gtr:description><gtr:id>2F346232-5659-42EA-AC19-7EBE84B8C8AE</gtr:id><gtr:impact>This collaboration was crucial in the development of my laboratory - allowing me to introduce mouse model systems into my programme of work. This was a critical aspect of the work currently being conducted under the auspices of my current MRC programme grant (G0600776). The sabbatical period for my student (Sherif F El Khamisy) also provided the experience necessary for him to deveop his own research laboratory, with subsequent funding from the Wellcome Trust. Several publications have emerged from this collaboration - one of which was financially supported by this grant (17914460)and two (19303373 &amp;amp; 19633665) that were supported by my current MRC programme grant (G0600776).</gtr:impact><gtr:partnerContribution>This collaboration enabled my group to introduce expertise in mouse model systmes into our work. This was necessary to progress our research into the link between single-strand break repair and neurodegenerative diseases.</gtr:partnerContribution><gtr:piContribution>My group provided expertise in the cellular analysis of single-strand break repair, and manpower (including a sabbatical period for one of my students)</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Work experience 2010-2013</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>CCED68E8-EE01-42FC-AEE9-E2ADAEE8180D</gtr:id><gtr:impact>Each year I host and organise a work experience week in for four-six children/yr from several local schools. During the week, the children participate in a variety of different scientific experiments in several different laboratories, with the intention of illustrating what a career in science is like.

schools typically receive great feedback from the students, who seem to enjoy the experience. This year, one school has also asked me to contribute to a career &amp;quot;speed dating&amp;quot; event in Jan 2013</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Centenary Exhibition</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>22A917D0-FEA2-49FC-96F1-B0B09C5ED7A0</gtr:id><gtr:impact>local school teachers/colleges and students/pupils visited a day of presentations on our research and its importance for health,culminating in several keynote talks that sparked discussion and conversation

this has encouraged further interest in our work experience week</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2447409</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>ERC Advanced Investigator Award</gtr:description><gtr:end>2021-09-02</gtr:end><gtr:fundingOrg>European Research Council (ERC)</gtr:fundingOrg><gtr:fundingRef>SIDSCA RC-2015-AdG-69499615</gtr:fundingRef><gtr:id>DBB34C43-C45A-42EE-A6DE-991A6FE9B0F0</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>360000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant 2012 (MR/K01854X/1)</gtr:description><gtr:end>2016-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/K01854X/1</gtr:fundingRef><gtr:id>96F4F76B-7030-421D-84F0-509E7304D7A3</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1940871</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Cellular and Pathological Responses to Chromosome DNA Single-Strand Breaks</gtr:description><gtr:end>2022-04-02</gtr:end><gtr:fundingOrg>MRC-UK</gtr:fundingOrg><gtr:fundingRef>MR/P010121/1</gtr:fundingRef><gtr:id>B75B315D-0A85-40EC-A2E4-ED40A46BCDF2</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2017-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>input into MRC strategy via MCMB</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FFD3BCB3-D754-4960-9DC8-0BBF435AECAC</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Input into MRC research straegy</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2479D2B1-C5B9-4D14-B48C-92386476CB82</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/16EC3447-C808-45D0-95E0-5C582F7345A6"><gtr:id>16EC3447-C808-45D0-95E0-5C582F7345A6</gtr:id><gtr:title>TDP2-dependent non-homologous end-joining protects against topoisomerase II-induced DNA breaks and genome instability in cells and in vivo.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cffc1dcecc4c0baa2ac7d37b3dd34adf"><gtr:id>cffc1dcecc4c0baa2ac7d37b3dd34adf</gtr:id><gtr:otherNames>G?mez-Herreros F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E02DE7C7-6ED4-4AA7-B670-A6CB5FE82FB0"><gtr:id>E02DE7C7-6ED4-4AA7-B670-A6CB5FE82FB0</gtr:id><gtr:title>XRCC1 mutation is associated with PARP1 hyperactivation and cerebellar ataxia.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/133bb285b0354b7e942a333966e7cdd9"><gtr:id>133bb285b0354b7e942a333966e7cdd9</gtr:id><gtr:otherNames>Hoch NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DF749AEB-C2A7-44D3-8D3F-417F380D44DD"><gtr:id>DF749AEB-C2A7-44D3-8D3F-417F380D44DD</gtr:id><gtr:title>TDP2 promotes repair of topoisomerase I-mediated DNA damage in the absence of TDP1.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/02a111a9043650e30f5eae331d4f2c9b"><gtr:id>02a111a9043650e30f5eae331d4f2c9b</gtr:id><gtr:otherNames>Zeng Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FDC9BC39-624E-4C74-896F-629F6C9AB923"><gtr:id>FDC9BC39-624E-4C74-896F-629F6C9AB923</gtr:id><gtr:title>The XRCC1 phosphate-binding pocket binds poly (ADP-ribose) and is required for XRCC1 function.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8ec0137267e8c769a95c7cae672f174b"><gtr:id>8ec0137267e8c769a95c7cae672f174b</gtr:id><gtr:otherNames>Breslin C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8ED38819-05BA-49EC-9DC1-7E63D8EA5C88"><gtr:id>8ED38819-05BA-49EC-9DC1-7E63D8EA5C88</gtr:id><gtr:title>Protein ADP-ribosylation and the cellular response to DNA strand breaks.</gtr:title><gtr:parentPublicationTitle>DNA repair</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/df98d3748be077b8e6cd59725a036bdb"><gtr:id>df98d3748be077b8e6cd59725a036bdb</gtr:id><gtr:otherNames>Caldecott KW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1568-7856</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5E09E035-4249-4E7D-ACB3-E26AF44171DE"><gtr:id>5E09E035-4249-4E7D-ACB3-E26AF44171DE</gtr:id><gtr:title>DNA single-strand break repair.</gtr:title><gtr:parentPublicationTitle>Experimental cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/df98d3748be077b8e6cd59725a036bdb"><gtr:id>df98d3748be077b8e6cd59725a036bdb</gtr:id><gtr:otherNames>Caldecott KW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0014-4827</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B292581A-DDD7-4E1F-B239-29AC570F2961"><gtr:id>B292581A-DDD7-4E1F-B239-29AC570F2961</gtr:id><gtr:title>Overlapping roles for PARP1 and PARP2 in the recruitment of endogenous XRCC1 and PNKP into oxidized chromatin.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/53e32fb6f4b117e6232f17eee8ee0961"><gtr:id>53e32fb6f4b117e6232f17eee8ee0961</gtr:id><gtr:otherNames>Hanzlikova H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D6987B0A-7298-4F31-A7CF-4D2475F4FA73"><gtr:id>D6987B0A-7298-4F31-A7CF-4D2475F4FA73</gtr:id><gtr:title>Molecular biology. Ribose--an internal threat to DNA.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/df98d3748be077b8e6cd59725a036bdb"><gtr:id>df98d3748be077b8e6cd59725a036bdb</gtr:id><gtr:otherNames>Caldecott KW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B71C22D0-B2BC-4F2C-9770-754723FD10B3"><gtr:id>B71C22D0-B2BC-4F2C-9770-754723FD10B3</gtr:id><gtr:title>PARP3 is a sensor of nicked nucleosomes and monoribosylates histone H2B(Glu2).</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ee1a81c67f608df4032a7745d1359901"><gtr:id>ee1a81c67f608df4032a7745d1359901</gtr:id><gtr:otherNames>Grundy GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/88D6F6EB-1EFE-4A7F-BEC5-07C268616B97"><gtr:id>88D6F6EB-1EFE-4A7F-BEC5-07C268616B97</gtr:id><gtr:title>Versatility in phospho-dependent molecular recognition of the XRCC1 and XRCC4 DNA-damage scaffolds by aprataxin-family FHA domains.</gtr:title><gtr:parentPublicationTitle>DNA repair</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/855494b73557f7c432cdf41869f3cb18"><gtr:id>855494b73557f7c432cdf41869f3cb18</gtr:id><gtr:otherNames>Cherry AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1568-7856</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/97227D48-1BED-4984-B047-6AF3F150CF7C"><gtr:id>97227D48-1BED-4984-B047-6AF3F150CF7C</gtr:id><gtr:title>PARP-1 dependent recruitment of the amyotrophic lateral sclerosis-associated protein FUS/TLS to sites of oxidative DNA damage.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9b65e5c2f5cfc13c162afd004ca52889"><gtr:id>9b65e5c2f5cfc13c162afd004ca52889</gtr:id><gtr:otherNames>Rulten SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0B002C4A-36E1-431A-B3CA-A48ED246A70A"><gtr:id>0B002C4A-36E1-431A-B3CA-A48ED246A70A</gtr:id><gtr:title>APLF promotes the assembly and activity of non-homologous end joining protein complexes.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ee1a81c67f608df4032a7745d1359901"><gtr:id>ee1a81c67f608df4032a7745d1359901</gtr:id><gtr:otherNames>Grundy GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3993A2B0-5B28-4FC9-8D6A-C3AE314C7EB6"><gtr:id>3993A2B0-5B28-4FC9-8D6A-C3AE314C7EB6</gtr:id><gtr:title>DNA strand break repair and neurodegeneration.</gtr:title><gtr:parentPublicationTitle>DNA repair</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9b65e5c2f5cfc13c162afd004ca52889"><gtr:id>9b65e5c2f5cfc13c162afd004ca52889</gtr:id><gtr:otherNames>Rulten SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1568-7856</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0B905504-BFE5-4BCD-901C-B8D7873A73A1"><gtr:id>0B905504-BFE5-4BCD-901C-B8D7873A73A1</gtr:id><gtr:title>Impact of PNKP mutations associated with microcephaly, seizures and developmental delay on enzyme activity and DNA strand break repair.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ae09bf89d0868254137b2df4bfae8f07"><gtr:id>ae09bf89d0868254137b2df4bfae8f07</gtr:id><gtr:otherNames>Reynolds JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/30516342-FB1A-4808-8BD9-AF484407EAE1"><gtr:id>30516342-FB1A-4808-8BD9-AF484407EAE1</gtr:id><gtr:title>TDP2 protects transcription from abortive topoisomerase activity and is required for normal neural function.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cffc1dcecc4c0baa2ac7d37b3dd34adf"><gtr:id>cffc1dcecc4c0baa2ac7d37b3dd34adf</gtr:id><gtr:otherNames>G?mez-Herreros F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/J006750/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>